Journal article
Gluten immunogenic peptide excretion detects dietary transgressions in treated celiac disease patients
Abstract
BACKGROUND: Life-long removal of gluten from the diet is currently the only way to manage celiac disease (CeD). Until now, no objective test has proven useful to objectively detect ingested gluten in clinical practice. Recently, tests that determine consumption of gluten by assessing excretion of gluten immunogenic peptides (GIP) in stool and urine have been developed. Their utility, in comparison with conventional dietary and analytical …
Authors
Costa AF; Sugai E; de la Paz Temprano M; Niveloni SI; Vázquez H; Moreno ML; Domínguez-Flores MR; Muñoz-Suano A; Smecuol E; Stefanolo JP
Journal
World Journal of Gastroenterology, Vol. 25, No. 11, pp. 1409–1420
Publisher
Baishideng Publishing Group
Publication Date
March 21, 2019
DOI
10.3748/wjg.v25.i11.1409
ISSN
1007-9327
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AdultAgedAged, 80 and overAsymptomatic DiseasesCeliac DiseaseCross-Sectional StudiesDiagnostic Self EvaluationDiet, Gluten-FreeEnzyme-Linked Immunosorbent AssayFecesFemaleGlutensHumansIntestinal EliminationMaleMiddle AgedPatient CompliancePeptidesPoint-of-Care TestingProspective StudiesSurveys and Questionnaires